Stakeholders call for hepatitis B, malaria testing guidelines
March 5, 2021
According to them, the guidelines will to ensure that accurate procedures are followed.
This would also help spell out how testing and vaccination should be done, especially to check whether a patient has been given a shot or not
Addressing participants in Accra yesterday, project coordinator for HEPMAL, Dr Kwadwo Asamoah Kusi,said the project, titled “Clinical andImmune pathological Consequences of Chronic HEPB and Plasmodium Falciparum-co infection”, seeks to assess the impact of both hepatitis B and malaria on the liver, as both diseases affect the liver.
“It is also expected to serve as a platform to conduct more research into hepatitis B for more evidence to educate the public on the need to check and know their status and get vaccinated”.
Effectiveness and cost-effectiveness of reactive, targeted indoor residual spraying for malaria control in low-transmission settings: a cluster-randomised, non-inferiority trial in South Africa thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.
Research Article
Birth weight, growth, nutritional status and mortality of infants from Lambaréné and Fougamou in Gabon in their first year of life
Rella Zoleko-Manego, Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Validation, Visualization, Writing – original draft, Writing – review & editing
Affiliations Centre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon, Institut für Tropenmedizin, Universität Tübingen, Tübingen, Germany, Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine & I. Dep. of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany Roles Formal analysis, Writing – original draft, Writing – review & editing
Affiliation Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine & I. Dep. of Medicine, University
Two HIV vaccine trials launched in Uganda
December 23, 2020 One of the volunteers getting the jab
PrEPVacc is, for the first time, trialing two HIV vaccine regimens in Uganda, and at the same time testing a new form of daily oral pre-exposure prophylaxis (PrEP) against the existing standard for PrEP.
The PrEPVacc trial, testing two ways to prevent HIV at the same time was launched on December 20 and begun giving its first injections and medicines to participants, at the Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine (MRC/UVRI and LSHTM) Uganda Research Unit, an official statement released on December 20, said.
EIB launches €50m Africa pharmaceutical manufacturing initiative - Pharmaceutical Business review pharmaceutical-business-review.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmaceutical-business-review.com Daily Mail and Mail on Sunday newspapers.